Noteworthy News Articles on Mental Health Topics, July 8-15, 2007
The drug, called varenicline, already is sold to help smokers kick the habit. New but preliminary research suggests it could gain a second use in helping heavy drinkers quit, too. Much further down the line, the tablets might be considered as a treatment for addictions to everything from gambling to painkillers, researchers said. Several experts not involved in the study cautioned that there is no such thing as a magic cure-all for addiction and that varenicline and similar drugs may find more immediate use in treating diseases like Alzheimer's and Parkinson's. Pfizer Inc. developed the drug specifically as a stop-smoking aid and has sold it in the United States since August under the brand name Chantix. Varenicline works by latching onto the same receptors in the brain that nicotine binds to when inhaled in cigarette smoke, an action that leads to the release of dopamine in the brain's pleasure centers. Taking the drug blocks any inhaled nicotine from reinforcing that effect. A study published Monday suggests not just nicotine but alcohol also acts on the same locations in the brain. That means a drug like varenicline, which makes smoking less rewarding, could do the same for drinking. Preliminary work, done in rats, suggests that is the case. ''The biggest thrill is that this drug, which has already proved safe for people trying to stop smoking, is now a potential drug to fight alcohol dependence,'' said Selena Bartlett, a neuroscientist with the Ernest Gallo Clinic and Research Center at the University of California, San Francisco who led the study. Details appear this week in the journal Proceedings of the National Academy of Sciences. Pfizer provided the drug for the study, but was not otherwise involved in the research. More often than not, smoking and drinking go together -- an observation pub-goers have made for hundreds of years. That a single drug could work to curb both addictions isn't a given -- nor is it surprising, said Christopher de Fiebre, an associate professor of pharmacology and neuroscience at the University of North Texas Health Science Center at Fort Worth. ''This is an extremely important paper and hopefully it will convince the major funding agencies that they need to examine the interactions between nicotine and alcohol to a greater extent than they have done to date,'' said de Fiebre, who was not connected with the study. In fact, the California researchers, together with the National Institute on Alcohol Abuse and Alcoholism, are now planning the first studies in humans of the drug's effectiveness in curbing alcohol cravings and dependence, Bartlett said. That the drug is already Food and Drug Administration-approved should speed things along. ''This is a drug that people are actually using. That's not trivial -- not at all,'' said Mark Egli, co-leader of the medications development program at the NIAAA, part of the National Institutes of Health. ''There is plenty of animal research that looks pretty cool but there is no way those drugs are ever going to be used by human beings.'' In the new study, researchers trained rats to drink alcohol and measured the effect of varenicline once the animals became the laboratory equivalent of heavy drinkers. They found the drug curbed their drinking. Even when stopped, the animals resumed drinking but didn't binge. Just as varenicline doesn't work for all smokers, it's highly unlikely it would for all drinkers. ''Is this going to be a cure-all? No, not for smoking or alcoholism because both diseases are more complicated than a single target or single genetic issue,'' said Allan Collins, a professor of pharmacology at the University of Colorado who was not connected to the study. Still, Collins, who's worked on the topic for decades, called the drug's potential use in treating alcoholism a ''no-brainer.'' And Egli said it supports the emerging view that there is a common biological basis for addictions to both alcohol and tobacco. As for Pfizer, the New York company has yet to decide whether to seek broader FDA approval for the drug, a spokesman said. ''Without having considerable more data on this it would be very difficult for us to say we might pursue it or not. It's almost a wait-and-see,'' said Pfizer's Stephen Lederer.
In 2005, the Food and Drug Administration, faced with evidence from controlled studies, mandated a “black box” notification on all antidepressant drugs, warning that their use in children and adolescents could increase the risk of suicide. In May, after reviewing controlled data from all age groups, the F.D.A. required an updated version to include a warning about suicide risk in young adults 18 to 24. The studies the F.D.A. analyzed, in which patients were followed closely and matched to controls, are considered the most direct way to analyze results. The two new studies were based on retrospective reviews of medical records. In one, researchers led by Dr. Gregory E. Simon, a psychiatrist with the Center for Health Studies in Seattle, reviewed the records of 109,356 people being treated for depression in a large prepaid health plan serving 500,000 people in Washington State and northern Idaho. They found that suicide attempts were most common in the month before treatment began, declined sharply in the month after it began, and tapered off in the following six months. All treatments — psychotherapy, medication or both — showed the same pattern, suggesting that treating depression reduced suicide risk regardless of technique. The authors acknowledged that they had no way to assess the severity of illness either before or after starting treatment, and that about a third of patients dropped out of treatment within a few weeks, two factors that may have influenced the results. Dr. Simon has received research grants and consulting fees from pharmaceutical companies. Dr. David Shaffer, a professor of pediatrics and psychiatry at Columbia who was not involved in the study, said the results should prove reassuring to people taking antidepressants. “The study provided no evidence that starting an antidepressant increases the likelihood of a suicide attempt,” he said. “Starting treatment, regardless of which kind, seems to reduce suicide attempts.” The second study was led by Robert D. Gibbons, director of the Center for Health Statistics at the University of Illinois at Chicago. Using medical data from the Veterans Health Administration, researchers found that among 226,866 adults with depression, the overall rate of suicide attempts after beginning treatment with a selective serotonin reuptake inhibitor, or S.S.R.I., was about one-third the rate of those who received no antidepressant at all. This was true for men 18 to 25 as well as for older adults. “The V.A. has a very good electronic medical record system, so this is likely to be reliable data,” said Dr. Nada Stotland, a professor of psychiatry at Rush Medical College in Chicago. “That makes these results even more powerful.” Dr. Stotland had no part in the study. The risk of suicide attempt was significantly higher before S.S.R.I. treatment than immediately after starting it, a finding that coincides with that of the Simon study. The scientists acknowledged that their patients were almost all men, and that they did not include any suicide attempts that did not result in contact with the Veterans Health Administration medical records system. One of the six authors has been a paid adviser to pharmaceutical companies. The authors of both papers worried that extending the boxed warning to young adults might discourage people from seeking effective treatment. “The F.D.A. didn’t say anything wrong in the warning,” Dr. Simon said. “I am 100 percent in support of the message that we need better follow-up care. But my concern is that the warning may scare people away from treatment.” Dr. Gibbons expressed similar concerns. “These two studies clearly show that the greatest risk for suicide is depression,” he said. “Failure to treat depression, either using pharmacotherapy or psychotherapy, will lead to dramatic increases in the rate of serious suicide attempts and completions in the U.S. and in the world.” Carter, Wellstone Push Mental Health Act Associated Press, 7/10/2007 WASHINGTON -- Rosalynn Carter teamed up with the son of the late Sen. Paul Wellstone on Tuesday to push for mental health insurance legislation, with the former first lady saying the goal has never been closer to realization. ''We've been working on this for so long, it finally seems to be in reach,'' said Carter, who has championed mental health causes for more than 35 years. David Wellstone hopes to carry out the legacy of his father, a Minnesota Democrat who died in a plane crash in 2002. ''Although he was passionate on many issues, there was not another issue that surpassed this in terms of his passion,'' David Wellstone said. Carter and Wellstone hope to win passage for the ''Paul Wellstone Mental Health and Addiction Equity Act,'' that would require equal health insurance coverage for mental and physical illnesses when policies include both. The two advocates, along with Rep. Patrick Kennedy, D-R.I., discussed the bill over lunch with The Associated Press on Tuesday, before testifying at a House subcommittee hearing on the bill. ''It's a moral issue,'' Carter said. David Wellstone recalled his father talking about his own brother's battle with mental illness, and said the experience motivated him to seek to better mental health coverage laws when he got to the Senate. In 1996, Wellstone and Sen. Pete Domenici, R-N.M., won passage of a law banning plans that offer mental health coverage from setting lower annual and lifetime spending limits for mental treatments than for physical ailments. The legislation in Congress would build on that by adding things like co-payments, deductibles and treatment limitations, a longtime goal of Paul Wellstone's. Patrick Kennedy said the bill's prospects have brightened not only because of a Democratic Congress, but also with more people getting sensitized to mental illness because of soldiers returning from Iraq with post-traumatic stress disorder. ''It's a much different environment now,'' said Kennedy, who has battled depression, alcoholism and drug abuse. But the legislation faces a competing bill in the Senate championed by Kennedy's father, Sen. Ted Kennedy, D-Mass. House advocates say it doesn't go far enough. The Senate bill came from a compromise following negotiations with businesses, the insurance industry and mental health advocates. Business and insurance groups fought previous versions, contending the legislation would drive up insurance costs. The House version says that if a plan provides mental health benefits, it must cover conditions provided by the health plan with the highest average enrollment of federal employees. The Senate bill lacks similar language. Another difference is that the Senate bill calls for pre-emption of state parity laws in treatment limitations and financial requirements. Rep. John Kline of Minnesota, the subcommittee's top Republican, said the House bill would drive up costs of health insurance. But Stephen Melek, an actuary with the firm Milliman, said his firm's analysis of the House bill estimated it would cause an increase of health insurance premiums of just 0.6 percent -- or $2.40 per member per month.
Such efforts -- often called reparative therapy or conversion therapy -- are considered futile and harmful by many gay-rights activists. Conservative groups defend the right to offer such treatment, and say people with their viewpoint have been excluded from the review panel. A six-member task force set up by the APA has its first meeting beginning next Tuesday. Already, scores of conservative religious leaders and counselors, representing such groups as the Southern Baptist Convention and Focus on the Family, have written a joint letter to the APA, expressing concern that the task force's proposals would not properly accommodate gays and lesbians whose religious beliefs condemn gay sex. ''We believe that psychologists should assist clients to develop lives that they value, even if that means they decline to identify as homosexual,'' said the letter, which requested a meeting between APA leaders and some of the signatories. APA spokeswoman Rhea Farberman said a decision on when and how to reply to the letter had not yet been made. The current APA policy, adopted in 1997, opposes any counseling that treats homosexuality as a mental illness, but does not explicitly denounce reparative therapy. The APA has decided to review the policy at a time when gay-rights groups are increasingly critical of such treatment and groups that support it. Conservatives contend that the review's outcome is preordained because the task force is dominated by gay-rights supporters. ''We're concerned,'' said Carrie Gordon Earll of Focus on the Family. ''The APA does not have a good track record of listening to other views.'' Joseph Nicolosi, a leading proponent of reparative therapy, predicted the task force would propose a ban of the practice -- and he vowed to resist such a move. Nicolosi, who was rejected as a task force nominee, is president of the National Association for Research and Therapy of Homosexuality. Clinton Anderson, director of the APA's Lesbian, Gay and Bisexual Concerns Office, insisted the panel would base its findings on scientific research, not ideology. He defended the decision to reject certain conservative applicants to the task force. ''We cannot take into account what are fundamentally negative religious perceptions of homosexuality -- they don't fit into our world view,'' Anderson said. One of the counselors denied a seat on the task force was Warren Throckmorton, a psychology professor at Grove City College near Pittsburgh. Though Throckmorton doesn't advocate a specific form of reparative therapy, he argues that psychologists should respect gay clients' religious beliefs in cases where the faith teaches that homosexual behavior is wrong. ''We work with clients to pursue their chosen values,'' he said. ''If they are core, unwavering commitments to their religious belief, therapists should not try to persuade them differently under the guise of science.'' However, one of the task force members, New York City psychiatrist Jack Drescher, said the conservatives don't acknowledge the harm that might be caused when a gay patient -- even voluntarily -- undergoes therapy to suppress or change sexual orientation. ''They want a rubber stamp of approval for a form of therapy that's questionable in its efficacy and they don't want to deal with the issue of harmful side effects,'' said Drescher, who is editor of the Journal of Gay and Lesbian Psychotherapy. As the APA planned the policy review, it received input from gay-rights groups, including Parents, Families and Friends of Lesbians and Gays. PFLAG's executive director, Jody Huckaby, said reparative therapy had been particularly harmful for young gays whose parents insisted on trying to change their sexual orientation. His group contends these efforts can cause depression and suicidal behavior. Current APA policy stipulates that no therapy should occur without ''informed consent'' of a gay or lesbian client. Jason Cianciotto of the National Gay and Lesbian Task Force said he hoped the APA would declare that no young person could ever be deemed to have given informed consent, and thus no reparative therapy would be approved for minors. The largest ministry that does counsel gays to change their sexual orientation is Exodus International. Its president, Alan Chambers -- who says prayer and therapy enabled him to move away from homosexuality -- is among those apprehensive of the APA review. ''I had hoped for more diversity on that panel,'' Chambers said. ''I see a lot of people who represent the other side -- who don't believe that people like me have a right to self-determination.'' The task force may submit a preliminary report to the APA's directors in December. Anderson said a final report might be completed by next March. On the Net: American Psychological Association: http://www.apa.org/ Laura Zigman, Washington Post- 7/10/2007 Everyone has a moment in time that divides his or her life into "before" and "after." For me that moment was 10 years ago, when I was 34. I had just left New York and moved to Washington -- trading my soul-deadening career and size-0 studio apartment for a 9-to-5 job and a big one-bedroom overlooking Rock Creek Park and the zoo, trading my no-life life for an actual life, not to put too fine a point on it, and feeling really good about it -- when depression struck. Again. The way it had repeatedly since second grade. It was then that I finally realized that I would never be able to outrun myself; wherever I went, wherever I moved, however stealthily I tried to sneak away, I would always bring myself with me. And at the thought of that -- at the thought of a life sentence with chronic clinical depression as my cellmate and no chance of parole -- I finally knew the jig was up. Uncle, I cried at long last. Give me the meds. Describing what depression feels like is a little like trying to describe what chocolate tastes like or what classical music sounds like or what red looks like. But for me, being depressed was like being inside a sealed glass box right in the middle of a big huge party: I could see out and people could see in, but that's about as far as it went. For most of my life I knew what I was missing out on -- everything -- and even though much of the time I was too depressed to care, every once in a while my heart would leap like a normal person's and I would grasp, in the flash of an instant, that my life was passing me by. Those times my spirit would float up to the ceiling and look down at myself pushing against the glass walls of my box like a frantic mime. But, like every other trapped mime in the history of the world, I could never find my way out. Caving in after a lifetime of refusing to "take the easy way out" was difficult. I had always been against medication in the treatment of depression -- for myself, not for others. My father had been depressed most of my life, and the Valium he'd taken during my childhood only seemed to make things worse. Even though I knew as an adult that it was stupid to prescribe a depressant to a depressive and that the newer generation of antidepressant drugs was much more effective, giving in to them still seemed somehow like cheating. After I'd gotten past the initial wave of feeling like a failure -- a failure at traditional psychotherapy, a failure at coping, a failure at life (take your pick!) -- I had other concerns. This was the mid-1990s, and every other week a big article or a big book about antidepressants appeared, reporting on the various side effects of psycho-pharmaceuticals. Given my luck -- which is to say, given my propensity for bad luck, like being born with a ridiculously disproportionate amount of negativity -- I assumed that I would get none of the drugs' positive effects and all of their bad side effects. But even if they just worked a little, maybe the frantic mime inside me would stop pounding pathetically on the glass and start feeling around for an exit door. Once I'd started taking the drugs, the mime inside me did more than that: It not only found the door and opened it -- it also ditched the white face and black jazz shoes on the way out. Within days, a lifetime of television-screen static and indecision and muteness lifted and was replaced by a focused clarity. Within weeks a new mental energy and ability to concentrate for long periods appeared. Before I knew it, I was able to whip through a week's to-do list in a single morning, make decisions without agonizing analysis-paralysis, and project myself into the future. My sock drawer and closets were organized, and my big black bag weighed half as much, now that several pounds of ATM receipts, shoes and loose tobacco had been removed. And I even finished rewriting the novel I'd been working on for five years. And that was only after the first three refills. Like any relationship, my partnership with medication these past 10 years has had its ups and downs. I've tried a few drugs that worked and a few drugs that didn't; I've gone off them a few times and suffered such severe withdrawal symptoms I feel I have some understanding of heroin addiction; and I've gone back on them every time because for me there is no question that I am happier -- or less unhappy, depending on whether I'm in a half-full or half-empty kind of mood -- when I am on medication. And despite the life-altering effect they've had on me, I accept that antidepressants can go only so far: I still hate going to parties, I still feel fat most of my waking hours, and I still worry that one day the sadness will come back and I won't be able to get out of bed. Just like going through childbirth with an epidural or dental surgery with a local anesthetic, there is still plenty of pain left over even with the drugs. Which is a good thing. I still like to go back and visit my glass box once in a while, to remember what it used to be like. Or maybe that's just the medication talking. Bad Memories? Forget About Them Denise Gellene, Los Angeles Times- 7/13/2007 Scientists have found evidence that people can actively suppress disturbing memories by choosing to not think about them, a finding that could lead to improved therapies for post-traumatic stress, whose sufferers are haunted by scary memories they can't control. By scanning the brains of 16 healthy adults who had been shown gruesome photographs, researchers from the University of Colorado discovered subjects' memory circuits slowed when they were instructed to push mental images of the photos from their minds. "You can train yourself to remember something, and you can train yourself to forget it," said University of Colorado graduate student Brendan E. Depue, lead author of the study published today in the journal Science. MIT neuroscientist John Gabrieli, who was not connected to the research, called the study "a big step forward." Previous experiments by Gabrieli and others have shown that subjects can suppress memories of neutral words and images, material viewed as more forgettable than gory scenes or personal trauma. "The great issues for memory suppression are emotionally intense experiences," he said, cautioning that no lab experiment can duplicate the trauma of real military combat or physical abuse. In the latest experiment, researchers trained test subjects to recognize 40 image pairs, each of which had an expressionless face and a murder scene, car crash or other disturbing picture. After they memorized the pairs, participants were shown only the faces and asked to "think" or "not think" about the corresponding image as a scanner recorded their brain activity. When subjects were told to block the disturbing image, the scanner recorded reduced activity in the brain regions that process and store memory. When asked to think about the images, activity in those brain regions increased. Researchers also conducted the test without the scanner by asking participants to write down whether they remembered or forgot the photo paired with each face. They were shown each face 12 times. When subjects tried to block the negative picture, they remembered it 53.2% of the time. But their recall rose to 71.1% when they tried to remember the disturbing scene. But some researchers questioned the study's conclusions. Craig Stark, an assistant professor of psychology at Johns Hopkins University School of Medicine who studies memory, said that deliberate memory suppression involved hard brain work. "You would expect brain activity to go up, not down," he said. Stark said the study demonstrated not memory suppression, but an ordinary sort of forgetfulness. "As you prevent yourself from thinking about something, you will keep yourself from reinforcing and consolidating that memory," he said. "At that point, a perfectly normal process of memory decay goes to work." James L. McGaugh, a UC Irvine professor who also studies memory, noted that the study examined retention of newly formed memories. "It would be a stretch to imagine this would apply to being able to suppress well-established, long-term memories," he said.
These cases are a sign of the growing strain on the state's overcrowded emergency rooms, doctors, nurses, patients and state officials said, and also reflect a shortage of services for the mentally ill, the challenge of caring for sometimes-aggressive psychiatric patients, and inconsistent training of harried ER staff. Emergency rooms can be battlegrounds. They often are the last resort for psychiatric patients in crisis -- some patients are so out of control and aggressive that mental health facilities will not take them -- and ERs have responded by creating "safe rooms" to handle such patients and on occasion calling in police for help, according to inter views with 20 doctors, nurses, patients, and hospital administrators. ER staff give psychiatric medications but are not trained to provide comprehensive psychiatric care, they said. And many of these patients stay in ERs for days without proper treatment because of backlogs in psychiatric facilities, creating potentially volatile situations for those patients, staff, and other patients. Hospital officials said nurses, too, have been injured in confrontations, and patients contend that they are humiliated by policies like the one requiring them to undress. Patients "will be in the ER from hours to days and they get absolutely no care," said Linda Condon, an emergency room nurse who has worked at four hospitals in Southeastern Massachusetts. "You put a person with psychiatric problems in a room with four walls and nothing to do, and there are going to be problems." Documents from the Department of Public Health -- which conducts investigations when patients or relatives complain or hospitals themselves report problems -- show that investigators cited 11 hospitals for a range of problems. Those cases include: A blind, disabled patient who went to Lawrence General Hospital in April because he was suicidal. Hospital policy then required psychiatric patients to undress so that staff could look for hidden drugs or weapons, but the patient wanted to keep on his jeans. A male nurse "used excessive force" to remove them, the health department found, breaking the patient's arm. The patient required surgery and a three-week hospital stay. In April 2006, a 49-year-old former nurse who arrived in the emergency room at Melrose-Wakefield Hospital at 10:30 p.m., intoxicated and uncooperative. Staff strapped down his arms and legs, gave him sedatives, and assigned a security guard to watch him. After a nurse called the security guard away to help with another violent patient, the first patient had a fatal cardiac arrest. The hospital's internal investigation determined that the patient was not properly monitored. Staff told state investigators that the ER was "very, very busy."In June 2006, a male teen in the Merrimack Valley Hospital ER in Haverhill began pulling medical equipment out of a wall, kicking furniture, and biting staff. While he was biting a nurse, a staff member repeatedly punched him in the face. State investigators said the hospital did not properly train staff on how to restrain patients. Hospital staff said punching was a last resort because the patient was severely injuring the nurse. State documents released to the Globe omitted the names of patients and staff for privacy reasons. When health officials find problems during investigations, hospitals must implement plans to correct them. The state public health and mental health departments have been so concerned about the pattern of complaints that they sent a memo to hospital executives in September, detailing 21 steps they should take to improve care of psychiatric patients in ERs, including reducing waiting times, using trained mediators, and further training staff in techniques to calm patients. But patients and advocates for people with mental illness say problems remain rampant. They are pushing legislators to increase the mental health department's role in regulating ER care and to require the public health department to develop "best practices" for treating psychiatric patients. "When we get upset and don't want to take our clothes off, they think we're going to flip out," said Constance Surette, 57, of Plymouth, who has bipolar disorder and works with a group pushing for legislation. "But the way they treat us, of course they're going to get that reaction. The ERs should use peer mediators to talk to [psychiatric patients] because they are frightened of the authority figures." Surette filed a complaint with the health department last month, alleging that city police officers at Quincy Medical Center sprayed one psychiatric patient with mace and handcuffed another to a bench while she was in the ER. Hospital spokeswoman Janice Sullivan said that she could not confirm Surette's account but that the actions taken were appropriate "for the safety of everyone involved." Doctors and nurses say they have made improvements but are doing the best they can in an impossible situation. They said the number of complaints statewide is small considering the thousands of psychiatric patients who seek care in Massachusetts ERs each year. In 2005, ERs reported 168,000 visits by psychiatric patients, 10 percent more than in 2003, according to the Massachusetts Health Data Consortium. And they usually have to wait longer for care. The average ER stay for patients who are eventually sent home or to another hospital is nearly three hours; it's nearly six hours for psychiatric patients. And many of these patients wait two to three days in the ER for an inpatient bed in a psychiatric facility to open."The emergency departments are overwhelmed," said Dr. Paul Bulat, medical director of the emergency room at St. Luke's Hospital in New Bedford. "We are seeing more violent patients and out-of-control patients. We're seeing mental health problems much worse than we should be." ER directors are reluctant to acknowledge that overcrowding hurts patient care. But staff told the state health department that busyness was a factor in several of the cases investigated, especially those that involved inadequate monitoring of patients. In the case of the former nurse who died at Melrose-Wakefield Hospital, not only did the security guard leave the patient alone for about 20 minutes, but the patient's condition was not checked every 15 minutes while he was restrained, as required by hospital policy. Monitoring is especially crucial for intoxicated patients who receive sedatives. Hospital spokesman Richard Pozniak said he could not comment on the case because of regulations requiring patient information to be kept confidential. State investigators said in their report that 13 patients were in the ER when the man arrived, and 20 other patients arrived before he died 4 1/2 hours later. Public health investigators also found that lack of training is an issue, including in cases where staff used excessive force. Better training in techniques to calm patients is especially important as frustrated psychiatric patients with no where else to go spend hours in the ER . In the case of the patient whose arm was broken at Lawrence General Hospital, investigators found a range of problems, including that the hospital's internal investigation of the complaint did not include interviewing the patient. Investigators also found no evidence that staff and security had been trained in patient's rights. And they said the nurse should have explored the patient's reasons for wanting to keep on his jeans before resorting to force. Hospital spokeswoman Ellen Murphy Meehan said the hospital "expressed deep regret to the patient" for what it considers an accident. She said Lawrence General has since changed its policy to allow some psychiatric patients to keep on their clothes and instead be frisked and scanned with a hand-held metal detector. Paul Dreyer, director of the state Division of Health Care Quality, said "a culture change" is needed; he is organizing an educational summit for ER staff in the fall, hoping hospitals will improve on their own, making legislation unnecessary. Legislators expect to hold hearings this summer or in the fall. We want "people to realize they don't have to call in security the first time someone looks at them cross-eyed," Dreyer said. "The ERs are in a production mode. Their aim is to process the patients as quickly as possible to get on to the next patient. These patients may not take well to being treated that way. They may act out." A number of hospitals said they have improved care after serious encounters. UMass Memorial Medical Center -- where campus police beat a psychiatric patient with a baton in 2004, injuring him, and, several months later, threw a patient against a wall and called her a "bitch," according to state reports -- said it has made significant changes. These include creating a secured, quiet area for psychiatric patients and training police to use calming techniques. Dr. Patrick Smallwood, medical director for emergency mental health services, also joined the hiring panel for campus police officers last year. Dr. Bruce Auerbach, chief for emergency and ambulatory services at Sturdy Memorial Hospital in Attleboro, said hospitals need more resources, not more regulation. "When a patient who is having a behavioral health crisis is in my ER for four days not getting the intervention he needs -- it's a travesty in our healthcare system," he said.
|